Results 1 to 10 of about 302,518 (309)

Interferon-α for Immune Modulation in Chronic Hepatitis B Toward Functional Cure [PDF]

Viruses
Chronic hepatitis B (CHB) remains a major global health challenge, largely due to the persistence of covalently closed circular DNA (cccDNA) and impaired host immunity.
Asha Ashuo, Jia Liu, Zhenghong Yuan, Jieliang Chen   +3 more
doaj   +2 more sources

Chronic hepatitis B [PDF]

Hepatology, 2001

Lok, Anna Suk-Fong, McMahon, Brian J.
  +10 more sources

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection

Vaccines, 2021
Chronic hepatitis B affects more than 250 million individuals worldwide, putting them at risk of developing liver cirrhosis and liver cancer. While antiviral immune responses are key to eliminating hepatitis B virus (HBV) infections, insufficient ...
Percy A. Knolle, Li-Rung Huang, Anna Kosinska, Dirk Wohlleber, Ulrike Protzer   +4 more
doaj   +1 more source

Effectiveness of hepatitis B hyperimmunglobulin and vaccine in preventing perinatal transmission in children born from a mother with chronic B hepatitis

Zdorovʹe Rebenka, 2021
Background. Viral hepatitis is still one of the important health problems all over the world today. Hepatitis B is a life-threatening liver infection that can cause chronic infections.
Feyza Gökben Kahveci, Hasret Ayyildiz Civan, Özgül Salihoğlu   +2 more
doaj   +1 more source

A Study of the Relationship between Oxidative Stress and Risk of Developing Hepatocellular Carcinoma in People with Hepatitis B Infection; A Systematic Review Study

Asian Pacific Journal of Cancer Biology, 2022
Introduction: Hepatitis B infection is a severe global public health issue. It is the 10th biggest cause of death worldwide. Objective: This review focuses on the relationship between oxidative stress and the risk of developing of acute and chronic ...
Hammadi Nour, Chouia Maroua, Derouiche Samir   +2 more
doaj   +1 more source

Acupuncture for chronic hepatitis B [PDF]

Cochrane Database of Systematic Reviews, 2018
Chronic hepatitis B is a liver disease associated with high morbidity and mortality. Chronic hepatitis B requires long-term management aiming to reduce the risks of hepatocellular inflammatory necrosis, liver fibrosis, decompensated liver cirrhosis, liver failure, and liver cancer, as well as to improve health-related quality of life.
Kong, De Zhao, Liang, Ning, Yang, Guan Lin, Zhang, Zhe, Liu, Yue, Yang, Ye, Liu, Yu Xi, Wang, Qi Ge, Zhang, Fan, Zhang, Hui Yong, Nikolova, Dimitrinka, Jakobsen, Janus C., Gluud, Christian, Liu, Jian Ping   +13 more
openaire   +4 more sources

Different profiles of neurocognitive impairment in patients with hepatitis B and C virus infections

Scientific Reports, 2022
The direct impact of chronic hepatitis B and hepatitis C on neurocognition remains elusive due to the frequent comorbidities, and the domains of the neurocognitive functions affected have rarely been investigated comprehensively.
Chun-Hsiang Tan, Meng-Chia Chang, Wei-Fang Tsai, Wan-Long Chuang, Jee-Fu Huang, Zu-Yau Lin, Chia-Yen Dai, Ming-Lun Yeh, Chi-Ting Li, Rwei-Ling Yu   +9 more
doaj   +1 more source

Chronic hepatitis B exhibited higher rate of hepatocellular carcinoma occurrence than hepatitis C in cirrhotic patients after effective antiviral treatment

Journal of the Formosan Medical Association, 2021
Background/Purpose: Effective antiviral-therapy can reduce the risk of liver cirrhosis related hepatocellular carcinoma in patients with chronic hepatitis B and hepatitis C. Yet, the difference of hepatocellular carcinoma development in chronic hepatitis
Ming-Tsung Lin, Kuo-Chin Chang, Yi-Hao Yen, Ming-Chao Tsai, Chien-Hung Chen, Jing-Houng Wang, Chang-Chun Hsiao, Yueh-Hsia Chiu, Tsung-Hui Hu   +8 more
doaj   +1 more source

Hepatitis B e antigen-negative chronic hepatitis B [PDF]

Hepatology, 2001
Summary HBeAg-negative CHB has now a worldwide distribution, developing in the course of HBeAg-positive chronic HBV infection during or after the phase of HBeAg loss and its seroconversion to anti-HBe. It is caused by replicating noncytopathic HBV mutants either unable to produce HBeAg (precore mutants) or with down-regulated transcription of the ...
Hadziyannis, SJ, Vassilopoulos, D
openaire   +3 more sources

The Dynamics of Incidence of Chronic Hepatitis B and C in the Population of Almaty city for 2001-2014 [PDF]

International Journal of Biomedicine, 2016
The results of a retrospective epidemiological analysis revealed a sharp decline in the incidence of acute hepatitis B among the entire population of Almaty and the absence of acute hepatitis B, acute hepatitis C and chronic hepatitis C among children ...
Maria N. Omarova, Lyazat Zh. Orakbay, Idelbay Kh. Shuratov, Aizhan B. Dzhumagalieva , Almas Umbetpaev   +4 more
doaj   +1 more source